GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd to consider Q2 FY27 results on Nov 3, 2026

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 29 Oct 2026, 03:34 PM IST  ·  BSE ID: 9d2969ea-8a12-4fd4-8fd3-ea71f379788f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors will meet to approve its financial performance for the latest quarter and half-year.
🤖 AI Summary
  • Jenburkt Pharmaceuticals Ltd board meeting scheduled for November 3, 2026.
  • Meeting to consider standalone unaudited financial results.
  • Results cover the quarter and half-year ended September 30, 2026.
  • Announcement is a continuation of earlier intimation dated September 22, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders will be affected once the financial results are disclosed and publicly available.
🔍
Management Signal
The scheduled board meeting signifies management's adherence to regular financial reporting timelines.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Jenburkt Pharmaceuticals board meeting on November 3, 2026.
Disclosure of standalone unaudited financial results for Q2 FY27.
Review of half-year financial performance ending September 30, 2026.
LOW RISK This filing is a routine intimation of a board meeting, not a release of material financial data.
💡 Investor Takeaway
Jenburkt Pharmaceuticals Ltd will announce its standalone unaudited financial results for the quarter and half-year ended September 30, 2026, at a board meeting on November 3, 2026.
❓ Frequently Asked Questions
When is Jenburkt Pharmaceuticals Ltd holding its board meeting?
Jenburkt Pharmaceuticals Ltd is holding a board meeting on Tuesday, November 3, 2026.
What will be discussed at the Jenburkt Pharmaceuticals board meeting?
The board meeting will discuss, among other things, the standalone unaudited financial results for the quarter and half-year ended September 30, 2026.
Is this a new announcement regarding the Jenburkt Pharmaceuticals board meeting?
No, this intimation is in continuation of an earlier letter dated September 22, 2026, regarding the board meeting.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.